skip to primary navigation skip to content

Response-Adaptive Randomisation in Clinical Trials Workshop

CRUK Cambridge Institute Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom

We will be hosting an in-person discussion workshop where a recent article entitled: Response-adaptive randomization in clinical trials: from myths to practical considerations and appearing in Statistical Science will be presented and discussed. The original discussion pieces that accompany the paper will be presented as well. Thursday 29th February, CRUK Cambridge Institute, Cambridge The event is aimed at […]


41st Fisher Memorial Lecture by Prof William Rosenberger

CRUK Cambridge Institute Li Ka Shing Centre, Robinson Way, Cambridge, United Kingdom

The MRC Biostatistics Unit is delighted to be hosting the 41st Fisher Memorial Lecture in conjunction with the Fisher Memorial Trust (FMT). The FMT was set up to promote interest in the life and work of the great statistician, evolutionary biologist and geneticist, Sir Ronald Aylmer Fisher (1890-1962) and to maintain his scientific legacy by encouraging discussion […]


BSU Seminar: “Uncertainty Quantification in the Digital Medicine Era”

MRC Biostatistics Unit East Forvie Building, Forvie Site, Robinson Way, Cambridge, United Kingdom

Speaker: Dr. Marcos Matabuena, Harvard University Abstract: The widespread use of wearable devices and smartphones has revolutionized the field of digital medicine, enabling non-invasive, continuous monitoring of various physiological parameters. This technological advancement is crucial for personalized medical and public health interventions. The data collected in free-living conditions are continuous (functional), collected at second or minute […]


BSU Seminar: “Using Joint Models for Longitudinal and Time-to-Event Data to Investigate the Causal Effect of Salvage Therapy after Prostatectomy”

Online , United Kingdom

Speaker: Dimitris Rizopoulos, Professor of Biostatistics, Erasmus Medical Center Rotterdam Summary: Prostate cancer patients who undergo prostatectomy are closely monitored for recurrence and metastasis using routine prostate-specific antigen (PSA) measurements. When PSA levels rise, salvage therapies are recommended to decrease the risk of metastasis. However, due to the side effects of these therapies and to […]